BARC provides full testing and data interpretation capabilities in AD regarding Aβ, Tau and p-Tau proteins and ApoE genotyping. For those tests, being performed routinely for medical diagnosis purposes, our experts provide up-to-date knowledge regarding both new and problematic healthcare trends in this market.
Regarding neurotransmission, testing of acetylcholine receptors and of acetylcholinesterase activity, measurements of glutamate and glutamic acid decarboxylase, are also available. A large panel of psycho-active drugs can also be measured.
In addition, BARC technology transfer and custom test capabilities provide our customers with a flexible platform for implementing new assays in clinical trials.